Factors influencing outcomes in cystic fibrosis: A center-based analysis

Charles Johnson, Steven M. Butler, Michael W. Konstan, Wayne J Morgan, Mary Ellen B Wohl

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

Context: Guidelines for managing cystic fibrosis (CF) patients have been widely circulated, but little is known about the variations in practice between sites and their association with outcomes. Objective: To determine whether differences in lung health existed between groups of patients attending different CF care sites and to determine whether these differences are associated with differences in monitoring and intervention. Design: The analysis was conducted using data from the Epidemiologic Study of Cystic Fibrosis from 1995 through 1996. Setting: This was an observational database collecting prospective information from a large number of CF patients undergoing routine care in North America. Participants: Participating sites that had at least 50 CF patients who had each made at least one visit to a center during the 2-year study period were ranked on the basis of median values for FEV1 within each of three age groups (6 to 12 years, 13 to 17 years, and ≥ 18 years). Interventions: There were no prespecified interventions in this observational study. Main outcome measures: The frequency of patient monitoring and the use of therapeutic interventions were compared between sites in the upper and lower quartiles after stratification within the site for disease severity. Results: Within-site rankings tended to be consistent across the three age groups. Patients who were treated at higher ranking sites had more frequent monitoring of their clinical status, measurements of lung function, and cultures for respiratory pathogens. These patients also received more interventions, particularly IV antibiotics for pulmonary exacerbations. Conclusion: We found substantial differences in lung health across different CF care sites. We found that frequent monitoring and increased use of appropriate medications in the management of CF are associated with improved outcomes.

Original languageEnglish (US)
Pages (from-to)20-27
Number of pages8
JournalChest
Volume123
Issue number1
DOIs
StatePublished - 2003

Fingerprint

Cystic Fibrosis
Lung
Age Groups
Health
Physiologic Monitoring
Therapeutic Uses
North America
Observational Studies
Epidemiologic Studies
Outcome Assessment (Health Care)
Databases
Guidelines
Anti-Bacterial Agents

Keywords

  • Cystic fibrosis
  • Epidemiology
  • Evaluation
  • Monitoring
  • Respiratory tract culture
  • Spirometry
  • Treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Johnson, C., Butler, S. M., Konstan, M. W., Morgan, W. J., & Wohl, M. E. B. (2003). Factors influencing outcomes in cystic fibrosis: A center-based analysis. Chest, 123(1), 20-27. https://doi.org/10.1378/chest.123.1.20

Factors influencing outcomes in cystic fibrosis : A center-based analysis. / Johnson, Charles; Butler, Steven M.; Konstan, Michael W.; Morgan, Wayne J; Wohl, Mary Ellen B.

In: Chest, Vol. 123, No. 1, 2003, p. 20-27.

Research output: Contribution to journalArticle

Johnson, C, Butler, SM, Konstan, MW, Morgan, WJ & Wohl, MEB 2003, 'Factors influencing outcomes in cystic fibrosis: A center-based analysis', Chest, vol. 123, no. 1, pp. 20-27. https://doi.org/10.1378/chest.123.1.20
Johnson, Charles ; Butler, Steven M. ; Konstan, Michael W. ; Morgan, Wayne J ; Wohl, Mary Ellen B. / Factors influencing outcomes in cystic fibrosis : A center-based analysis. In: Chest. 2003 ; Vol. 123, No. 1. pp. 20-27.
@article{6e704eb28f6a43d396457930dbb6a462,
title = "Factors influencing outcomes in cystic fibrosis: A center-based analysis",
abstract = "Context: Guidelines for managing cystic fibrosis (CF) patients have been widely circulated, but little is known about the variations in practice between sites and their association with outcomes. Objective: To determine whether differences in lung health existed between groups of patients attending different CF care sites and to determine whether these differences are associated with differences in monitoring and intervention. Design: The analysis was conducted using data from the Epidemiologic Study of Cystic Fibrosis from 1995 through 1996. Setting: This was an observational database collecting prospective information from a large number of CF patients undergoing routine care in North America. Participants: Participating sites that had at least 50 CF patients who had each made at least one visit to a center during the 2-year study period were ranked on the basis of median values for FEV1 within each of three age groups (6 to 12 years, 13 to 17 years, and ≥ 18 years). Interventions: There were no prespecified interventions in this observational study. Main outcome measures: The frequency of patient monitoring and the use of therapeutic interventions were compared between sites in the upper and lower quartiles after stratification within the site for disease severity. Results: Within-site rankings tended to be consistent across the three age groups. Patients who were treated at higher ranking sites had more frequent monitoring of their clinical status, measurements of lung function, and cultures for respiratory pathogens. These patients also received more interventions, particularly IV antibiotics for pulmonary exacerbations. Conclusion: We found substantial differences in lung health across different CF care sites. We found that frequent monitoring and increased use of appropriate medications in the management of CF are associated with improved outcomes.",
keywords = "Cystic fibrosis, Epidemiology, Evaluation, Monitoring, Respiratory tract culture, Spirometry, Treatment",
author = "Charles Johnson and Butler, {Steven M.} and Konstan, {Michael W.} and Morgan, {Wayne J} and Wohl, {Mary Ellen B}",
year = "2003",
doi = "10.1378/chest.123.1.20",
language = "English (US)",
volume = "123",
pages = "20--27",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Factors influencing outcomes in cystic fibrosis

T2 - A center-based analysis

AU - Johnson, Charles

AU - Butler, Steven M.

AU - Konstan, Michael W.

AU - Morgan, Wayne J

AU - Wohl, Mary Ellen B

PY - 2003

Y1 - 2003

N2 - Context: Guidelines for managing cystic fibrosis (CF) patients have been widely circulated, but little is known about the variations in practice between sites and their association with outcomes. Objective: To determine whether differences in lung health existed between groups of patients attending different CF care sites and to determine whether these differences are associated with differences in monitoring and intervention. Design: The analysis was conducted using data from the Epidemiologic Study of Cystic Fibrosis from 1995 through 1996. Setting: This was an observational database collecting prospective information from a large number of CF patients undergoing routine care in North America. Participants: Participating sites that had at least 50 CF patients who had each made at least one visit to a center during the 2-year study period were ranked on the basis of median values for FEV1 within each of three age groups (6 to 12 years, 13 to 17 years, and ≥ 18 years). Interventions: There were no prespecified interventions in this observational study. Main outcome measures: The frequency of patient monitoring and the use of therapeutic interventions were compared between sites in the upper and lower quartiles after stratification within the site for disease severity. Results: Within-site rankings tended to be consistent across the three age groups. Patients who were treated at higher ranking sites had more frequent monitoring of their clinical status, measurements of lung function, and cultures for respiratory pathogens. These patients also received more interventions, particularly IV antibiotics for pulmonary exacerbations. Conclusion: We found substantial differences in lung health across different CF care sites. We found that frequent monitoring and increased use of appropriate medications in the management of CF are associated with improved outcomes.

AB - Context: Guidelines for managing cystic fibrosis (CF) patients have been widely circulated, but little is known about the variations in practice between sites and their association with outcomes. Objective: To determine whether differences in lung health existed between groups of patients attending different CF care sites and to determine whether these differences are associated with differences in monitoring and intervention. Design: The analysis was conducted using data from the Epidemiologic Study of Cystic Fibrosis from 1995 through 1996. Setting: This was an observational database collecting prospective information from a large number of CF patients undergoing routine care in North America. Participants: Participating sites that had at least 50 CF patients who had each made at least one visit to a center during the 2-year study period were ranked on the basis of median values for FEV1 within each of three age groups (6 to 12 years, 13 to 17 years, and ≥ 18 years). Interventions: There were no prespecified interventions in this observational study. Main outcome measures: The frequency of patient monitoring and the use of therapeutic interventions were compared between sites in the upper and lower quartiles after stratification within the site for disease severity. Results: Within-site rankings tended to be consistent across the three age groups. Patients who were treated at higher ranking sites had more frequent monitoring of their clinical status, measurements of lung function, and cultures for respiratory pathogens. These patients also received more interventions, particularly IV antibiotics for pulmonary exacerbations. Conclusion: We found substantial differences in lung health across different CF care sites. We found that frequent monitoring and increased use of appropriate medications in the management of CF are associated with improved outcomes.

KW - Cystic fibrosis

KW - Epidemiology

KW - Evaluation

KW - Monitoring

KW - Respiratory tract culture

KW - Spirometry

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0037252230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037252230&partnerID=8YFLogxK

U2 - 10.1378/chest.123.1.20

DO - 10.1378/chest.123.1.20

M3 - Article

C2 - 12527598

AN - SCOPUS:0037252230

VL - 123

SP - 20

EP - 27

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -